Trial Details

Not Recruiting
Basic Information
Clinical ID c3352
Identifier EUCTR2006-003328-12-AT
Trial Title A multi-centre, randomized, controlled, single-blinded, phase II study to investigate the safety and efficacy of intravenous infusions of FERINJECT versus placebo in patients with thrombocytosis secondary to iron deficiency and chronic inflammatory bowel disease - ThromboVIT
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Persons with Inflammatory Bowel Disease, thrombocytosis and iron deficiency
Interventions Product Name: Ferinject Product Code: Vit-45 Pharmaceutical Form: Intravenous infusion Pharmaceutical form of the placebo: Intravenous infusion Route of administration of the placebo: Intravenous use
Participant Information
Sponsor Vifor Int.
City -
Country/Region Austria
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -